These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24227593)

  • 21. Singular DYT6 phenotypes in association with new THAP1 frameshift mutations.
    Blanchard A; Roubertie A; Simonetta-Moreau M; Ea V; Coquart C; Frederic MY; Gallouedec G; Adenis JP; Benatru I; Borg M; Burbaud P; Calvas P; Cif L; Damier P; Destee A; Faivre L; Guyant-Marechal L; Janik P; Janoura S; Kreisler A; Lusakowska A; Odent S; Potulska-Chromik A; Rudzińska M; Thobois S; Vuillaume I; Tranchant C; Tuffery-Giraud S; Coubes P; Sablonnière B; Claustres M; Collod-Béroud G
    Mov Disord; 2011 Aug; 26(9):1775-7. PubMed ID: 21520283
    [No Abstract]   [Full Text] [Related]  

  • 22. Joint hypermobility syndrome: a risk factor for fixed dystonia?
    Kassavetis P; Batla A; Pareés I; Saifee TA; Schrag A; Cordivari C; Bhatia KP; Edwards MJ
    Mov Disord; 2012 Jul; 27(8):1070. PubMed ID: 22532260
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of sequence variations in THAP1 gene and THAP1-binding sites in TOR1A promoter of DYT1 patients.
    Palada V; Stiern S; Glöckle N; Gómez-Garre P; Carrillo F; Mir P; Szczaluba K; Tinazzi M; Ajena D; Romani M; Valente EM; Müller U; Bauer P; Riess O; Ott T; Grundmann K
    Mov Disord; 2012 Jun; 27(7):917. PubMed ID: 22508326
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustained relief after discontinuation of DBS for dystonia: implications for the possible role of synaptic plasticity and cortical reorganization.
    Stavrinou LC; Boviatsis EJ; Stathis P; Leonardos A; Panourias IG; Sakas DE
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):175-8; discussion 178-9. PubMed ID: 21630190
    [No Abstract]   [Full Text] [Related]  

  • 25. A molecular link between dystonia 1 and dystonia 6?
    Müller U
    Ann Neurol; 2010 Oct; 68(4):418-20. PubMed ID: 20976763
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistent chorea in DYT6, due to anticholinergic therapy.
    Antelmi E; Erro R; Pisani A; Mencacci N; Bhatia KP
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1282-3. PubMed ID: 26275586
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening of Brazilian families with primary dystonia reveals a novel THAP1 mutation and a de novo TOR1A GAG deletion.
    De Carvalho Aguiar P; Fuchs T; Borges V; Lamar KM; Silva SM; Ferraz HB; Ozelius L
    Mov Disord; 2010 Dec; 25(16):2854-7. PubMed ID: 20925076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrafamilial variability of the primary dystonia DYT6 phenotype caused by p.Cys5Trp mutation in THAP1 gene.
    Jurek M; Hoffman-Zacharska D; Koziorowski D; Mądry J; Friedman A; Bal J
    Neurol Neurochir Pol; 2014; 48(4):254-7. PubMed ID: 25168324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular distribution of THAP1 and alterations in the microstructure of brain white matter in DYT6 dystonia.
    Cheng FB; Wan XH; Feng JC; Ma LY; Hou B; Feng F; Wang L; Yang YM
    Parkinsonism Relat Disord; 2012 Sep; 18(8):978-82. PubMed ID: 22652465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dystonia-Causing Mutations as a Contribution to the Etiology of Spasmodic Dysphonia.
    de Gusmão CM; Fuchs T; Moses A; Multhaupt-Buell T; Song PC; Ozelius LJ; Franco RA; Sharma N
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):624-8. PubMed ID: 27188707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate response to botulinum toxin injections in patients with fixed dystonia.
    Edwards MJ; Bhatia KP; Cordivari C
    Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
    [No Abstract]   [Full Text] [Related]  

  • 32. DYT6 dystonia: review of the literature and creation of the UMD Locus-Specific Database (LSDB) for mutations in the THAP1 gene.
    Blanchard A; Ea V; Roubertie A; Martin M; Coquart C; Claustres M; Béroud C; Collod-Béroud G
    Hum Mutat; 2011 Nov; 32(11):1213-24. PubMed ID: 21793105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for rare sequence variants in the THAP1 gene in a primary dystonia cohort.
    Newman JR; Lehn AC; Boyle RS; Silburn PA; Mellick GD
    Mov Disord; 2013 Oct; 28(12):1752-3. PubMed ID: 23649788
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel THAP1 missense variant with incomplete penetrance in a case of generalized young onset dystonia showing good response to deep brain stimulation.
    Keller Sarmiento IJ; Fraint A; Kinsley L; Akhtar RS; Silani V; Lubbe SJ; Krainc D; Mencacci NE
    Parkinsonism Relat Disord; 2022 Dec; 105():7-8. PubMed ID: 36323131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and therapeutic aspects in Tunisian patients with dystonia: a 5-year prospective study].
    Benrhouma H; Kraoua I; Klaa H; Rouissi A; Turki I; Gouider-Khouja N
    Rev Neurol (Paris); 2013 Jan; 169(1):47-52. PubMed ID: 22633313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical syndrome of primary tic disorder associated with dystonia: a large clinical series and a review of the literature.
    Damásio J; Edwards MJ; Alonso-Canovas A; Schwingenschuh P; Kägi G; Bhatia KP
    Mov Disord; 2011 Mar; 26(4):679-84. PubMed ID: 21506147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The syndrome of deafness-dystonia: clinical and genetic heterogeneity.
    Kojovic M; Pareés I; Lampreia T; Pienczk-Reclawowicz K; Xiromerisiou G; Rubio-Agusti I; Kramberger M; Carecchio M; Alazami AM; Brancati F; Slawek J; Pirtosek Z; Valente EM; Alkuraya FS; Edwards MJ; Bhatia KP
    Mov Disord; 2013 Jun; 28(6):795-803. PubMed ID: 23418071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New approaches in dystonia (clinical features, genetic issues and pathophysiology].
    Vidailhet M; Grabli D
    Bull Acad Natl Med; 2011; 195(4-5):921-34; discussion 934. PubMed ID: 22375360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.